rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    PRPO
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Precipio Announces Q3-2026 Financial Results
      Nov 11BenzingaPRPO
      Precipio, Inc. Q3 2026 Earnings Call Summary
      Nov 11Yahoo FinancePRPO
      Earnings call transcript: Precipio shares rise on q3 2026 growth outlook
      Nov 11Investing.comPRPO
      Precipio Q3 2026 Earnings Call Transcript
      Nov 10BenzingaPRPO
      Precipio Announces Q3-2026 Shareholder Update Call
      Oct 29BenzingaPRPO
      Precipio: Management Dreams Big, Institutions Have A Toe In (NASDAQ:PRPO)

      Precipio (PRPO) stock update: razor/razor-blades cancer diagnostics, insider + Vanguard/BlackRock ownership, breakeven cash flow, 30% growth.

      Oct 12Seeking AlphaPRPO
      PRPO vs. FLGT: Which Cancer Diagnostics Stock Has More Upside Now?

      Detailed price information for Precipio Inc (PRPO-Q) from The Globe and Mail including charting and trades.

      Sep 22The Globe and MailFLGTPRPO
      Precipio Q2 2026 Earnings Call: Complete Transcript
      Sep 18BenzingaPRPO
      The Zacks Analyst Blog Highlights Goldman Sachs, RTX, Abbott, NLI and Precipio

      Goldman Sachs, RTX and Abbott lead Zacks' latest research, with growth drivers balanced by costs, supply-chain and market risks.

      Sep 11Yahoo FinancePRPOABTGS
      Precipio Stock Gains Post Q2 Earnings, Revenue Momentum Strong

      PRPO's second-quarter 2026 revenue momentum strengthens on higher diagnostic volumes and record product sales, alongside positive adjusted EBITDA and cash generation.

      Aug 21Yahoo FinancePRPO

      This is the newest page. Registered accounts read further back.